Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Hematopoietic stem cell transplantation: clinical use and perspectives.

Barriga F, Ramírez P, Wietstruck A, Rojas N.

Biol Res. 2012;45(3):307-16. doi: 10.4067/S0716-97602012000300012.

2.

Umbilical cord blood transplantation: the first 20 years.

Wagner JE, Gluckman E.

Semin Hematol. 2010 Jan;47(1):3-12. doi: 10.1053/j.seminhematol.2009.10.011. Review.

PMID:
20109607
3.

Stem cell transplantation: past, present and future.

Thomas ED Sr.

Stem Cells. 1994 Nov;12(6):539-44. Review.

PMID:
7881356
4.
5.

Reduced-intensity conditioning for the treatment of malignant and life-threatening non-malignant disorders.

Slavin S, Aker M, Shapira MY, Resnick I, Bitan M, Or R.

Clin Transpl. 2003:275-82. Review.

PMID:
15387119
6.

Non-myeloablative stem cell transplantation and donor lymphocyte infusion for the treatment of cancer and life-threatening non-malignant disorders.

Slavin S, Nagler A, Aker M, Shapira MY, Cividalli G, Or R.

Rev Clin Exp Hematol. 2001 Jun;5(2):135-46. Review.

PMID:
11486652
7.

Recent advances in hematopoietic stem cell transplantation and perspectives of RNAi applications.

Fløisand Y, Sioud M.

Methods Mol Biol. 2010;629:507-23. doi: 10.1007/978-1-60761-657-3_30. Review.

PMID:
20387168
8.

Transplantation of hematopoietic stem cells from the peripheral blood.

Jansen J, Hanks S, Thompson JM, Dugan MJ, Akard LP.

J Cell Mol Med. 2005 Jan-Mar;9(1):37-50. Review.

9.

[Current status and issues in hematopoietic stem cell transplantation].

Harada M.

Fukuoka Igaku Zasshi. 2007 Feb;98(2):35-47. Review. Japanese. No abstract available.

PMID:
17396570
10.

Hematopoietic cell transplantation: five decades of progress.

Baron F, Storb R, Little MT.

Arch Med Res. 2003 Nov-Dec;34(6):528-44. Review.

11.

Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.

Watt SM, Austin E, Armitage S.

Methods Mol Biol. 2007;368:237-59. Review.

PMID:
18080475
12.

[Umbilical cord blood as a source of stem cells].

Bojanić I, Golubić Cepulić B.

Acta Med Croatica. 2006 Jun;60(3):215-25. Review. Croatian.

PMID:
16933834
13.

Non-myeloablative stem cell transplantation for the treatment of cancer and life-threatening non-malignant disorders; past accomplishments and future goals.

Slavin S, Aker M, Shapira MY, Panigrahi S, Gabriel C, Or R.

Transfus Apher Sci. 2002 Oct;27(2):159-66. Review.

PMID:
12350051
14.

[Allogeneic hematopoietic stem cell transplantations].

Michallet M.

Transfus Clin Biol. 2011 Apr;18(2):235-45. doi: 10.1016/j.tracli.2011.02.021. Epub 2011 Apr 3. Review. French.

PMID:
21466967
15.

Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases.

Resnick IB, Shapira MY, Slavin S.

Transpl Immunol. 2005 Aug;14(3-4):207-19. Epub 2005 Apr 26. Review.

PMID:
15982565
16.

Organization and Development of Bone Marrow Donation and Transplantation in Poland.

Filipiak J, Dudkiewicz M, Czerwiński J, Kosmala K, Łęczycka A, Malanowski P, Żalikowska-Hołoweńko J, Małkowski P, Danielewicz R.

Ann Transplant. 2015 Oct 1;20:588-95. doi: 10.12659/AOT.894285. Review.

17.

Hematopoietic stem cell transplantation for systemic sclerosis: history and current status.

Burt RK, Milanetti F.

Curr Opin Rheumatol. 2011 Nov;23(6):519-29. doi: 10.1097/BOR.0b013e32834aa45f. Review.

PMID:
21857226
19.

[Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].

Michallet M, Dhedin N, Michallet AS.

Bull Cancer. 2001 Sep;88(9):908-26. Review. French.

20.

Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program.

Bolan CD, Hartzman RJ, Perry EH, Trainor L, Miller J, Miller R, Hanley L, Chitphakdithai P, King RJ.

Biol Blood Marrow Transplant. 2008 Sep;14(9 Suppl):23-8. doi: 10.1016/j.bbmt.2008.06.001. Review.

Supplemental Content

Support Center